Glucocorticoids for Preventing Migraine Recurrence in the Emergency Department

JAMA Neurology 2026

View at publisher
Authors: Amy A. Gelfand, Serena Laura Orr, Daniel J. Shapiro
DOI: 10.1001/jamaneurol.2025.5493
Cited by: 0
References: 9

Abstract

This Viewpoint discusses glucocorticoid recommendations for treating migraine in the emergency department (ED), describing the potential for harm that means it should not be a reflexive first-line choice for either children or adults.

Fields of Study & Subjects

Migraine and Headache Studies Acute Ischemic Stroke Management Intracranial Aneurysms: Treatment and Complications

Publication details

Journal / source
JAMA Neurology
Volume
83
Issue
5
Pages
415–415
Publication date
9 February 2026
Language
EN